Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 40
- Next page
Title | Authors | Year | Journal | Link to Article | Intended Audience Sort descending | Purpose |
---|---|---|---|---|---|---|
CMV Seronegative, irradiated, and washed blood components | Prokopchuk-Gauk O, Solh Z | 2016 | Clinical Guide to Transfusion | View CMV Seronegative, irradiated, and washed blood components | Health care providers | Other |
Exploratory studies on the age of transfused blood and in-hospital mortality in patients with cardiovascular diagnoses | Heddle NM, Eikelboom J, Liu Y, Barty R, Cook RJ | 2015 | Transfusion | View Exploratory studies on the age of transfused blood and in-hospital mortality in patients with cardiovascular diagnoses | Health care providers | Clinical research |
Platelet Transfusion Practices in the Intensive Care Unit: Data from a Large Transfusion Registry | Ning S, Barty R, Liu Y, Heddle NM, Rochwerg B, Arnold DM | 2016 | Chest | View Platelet Transfusion Practices in the Intensive Care Unit: Data from a Large Transfusion Registry | Health care providers | Clinical research |
Utilization of frozen plasma, cryoprecipitate, and recombinant factor VIIa for children with hemostatic impairments: An audit of transfusion appropriateness | Lieberman L, Lin Y, Cserti-Gazdewich C, Yi QL, Pendergrast J, Lau W, Callum J | 2018 | Pediatr Blood Cancer | View Utilization of frozen plasma, cryoprecipitate, and recombinant factor VIIa for children with hemostatic impairments: An audit of transfusion appropriateness | Health care providers | Clinical research |
La maladie hémolytique du foetus et du nouveau-né et thrombopénie immune périnatale | Clarke G, Hannon J | 2018 | Guide de la pratique transfusionnelle | View La maladie hémolytique du foetus et du nouveau-né et thrombopénie immune périnatale | Health care providers | Other |
Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH | Ragni MV, Croteau SE, Morfini M, Cnossen MH, Iorio A | 2018 | J Thromb Haemost | View Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH | Health care providers | Basic research |
Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene | Warkentin TE | 2018 | J Thromb Haemost | View Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene | Health care providers | Benchmarking and standard setting |
Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A | Shah A, Solms A, Wiegmann S, Ahsman M, Berntorp E, Tiede A, Iorio A, Mancuso ME, Zhivkov T, Lissitchkov T | 2019 | Ann Hematol | View Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A | Health care providers | Clinical research |
Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals | Hill-Strathy M, Pinkerton PH, Thompson TA, Wendt A, Collins A, Cohen R, WO BC, Cameron T, Lin Y, Lau W, Lieberman L, Callum J | 2021 | Transfusion | View Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals | Health care providers | Clinical research |
Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010–2011 to 2016–2017 | Skowronski DM, Zou M, Clarke Q, Chambers C, Dickinson JA, Sabaiduc S, Olsha R, Gubbay JB, Drews SJ, Charest H, Winter A-L, Jassem A, Murti M, Krajden M, De Serres G | 2020 | Clin Infect Dis | View Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010–2011 to 2016–2017 | Health care providers | Clinical research |
Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial | Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Amini S, Schipperus M, Lim W, Vishnu P, Warner M, Carruthers J, Li N, Lane S, Kelton JG | 2020 | Lancet Haematol | View Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial | Health care providers | Clinical research |
Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Hadjesfandiari N, Levin E, Serrano K, Yi Q-L, Devine DV | 2021 | Transfusion | View Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC) Cord Blood | Stewart T | 2021 | Blood.ca website | View Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC) Cord Blood | Health care providers | Benchmarking and standard setting |
Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B | Olasupo OO, Lowe MS, Krishan A, Collins P, Iorio A, Matino D | 2021 | Cochrane Database Syst Rev | View Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B | Health care providers | Clinical research |
International Forum on Policies and Practice for Transfusion of ABO and RhD Non-Identical Platelets: Summary | Cardigan R, New HV, Estcourt L, Zhiburt E, Dubey R, Bengtsson J, Jöud M, Castillo C, Cid J, Lozano M, Gounder D, Flanagan P, Morley S, Clarke G, Devine D, Hindawi S, AlOtaibi A, Bub CB, Kutner JM, Ikeda T, Goto N, Okazaki H, Fontaine MJ, Pasion J, Song L, Latham T, Kerkhoffs JL, de Haas M, Zwaginga JJ, Gathof BS, Ommer K, Pirenne F, Raba M, Francois A, Daly J, Powley T, Dunbar N | 2022 | Vox Sang | View International Forum on Policies and Practice for Transfusion of ABO and RhD Non-Identical Platelets: Summary | Health care providers | Benchmarking and standard setting |
Novel platelet products including cold-stored platelets | Devine DV | 2022 | Hematology | View Novel platelet products including cold-stored platelets | Health care providers | New or improved product or process |
Investigation of Acute Transfusion Reactions | Leary H, Webert KE, Heddle NM | 2022 | Practical Transfusion Medicine | View Investigation of Acute Transfusion Reactions | Health care providers | Benchmarking and standard setting |
Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma | Mian H, Warkentin TE, Sheppard JI, MacDonald A, Linkins LA, Benger A, Foley R | 2017 | Blood | View Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma | Health care providers | Clinical research |
Blood component transfusion in critically ill patients | McIntyre L, Tinmouth AT, Fergusson DA | 2013 | Curr Opin Crit Care | View Blood component transfusion in critically ill patients | Health care providers | Clinical research |
Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis | Molnar AO, Fergusson D, Tsampalieros AK, Bennett A, Fergusson N, Ramsay T, Knoll GA | 2015 | BMJ | View Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis | Health care providers | Clinical research |
Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation | Christou G, Kekre N, Petrcich W, Tokessy M, Neurath D, Giulivi A, Saidenberg E, McDiarmid S, Atkins H, Bence-Bruckler I, Bredeson C, Huebsch L, Sabloff M, Sheppard D, Tay J, Tinmouth A, Allan DS | 2015 | Transfusion | View Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation | Health care providers | Clinical research |
Interpretation of pretransfusion testing in obstetrical patients who have received antepartum Rh immunoglobulin prophylaxis | Szkotak AJ, Lunty B, Nahirniak S, Clarke G | 2016 | Vox Sang | View Interpretation of pretransfusion testing in obstetrical patients who have received antepartum Rh immunoglobulin prophylaxis | Health care providers | Clinical research |
Platelets in Thrombosis and Hemostasis: Old Topic with New Mechanisms | Wang Y, Andrews M, Yang Y, Lang S, Jin JW, Cameron-Vendrig A, Zhu G, Reheman A, Ni H | 2012 | Cardiovasc Hematol Disord Drug Targets | View Platelets in Thrombosis and Hemostasis: Old Topic with New Mechanisms | Health care providers | Basic research |
Prophylactic platelet transfusions: should they be a treatment of the past? | Zeller MP, Al-Habsi KS, Heddle NM | 2014 | Curr Opin Hematol | View Prophylactic platelet transfusions: should they be a treatment of the past? | Health care providers | Clinical research |
Resolving variable maternal D typing using serology and genotyping in selected prenatal patients | Clarke G, Hannon J, Berardi P, Barr G, Cote J, Fallis R, Alport T, Lane D, Petraszko T, Ochoa G, Goldman M | 2016 | Transfusion | View Resolving variable maternal D typing using serology and genotyping in selected prenatal patients | Health care providers | New or improved product or process |
Successful treatment with oseltamivir phosphate in a patient with chronic immune thrombocytopenia positive for anti-GPIb/IX autoantibody | Shao L, Wu Y, Zhou H, Qin P, Ni H, Peng J, Hou M | 2014 | Platelets | View Successful treatment with oseltamivir phosphate in a patient with chronic immune thrombocytopenia positive for anti-GPIb/IX autoantibody | Health care providers | Clinical research |
Thrombocytopenic syndromes in pregnancy | Yan M, Malinowski AK, Shehata N | 2016 | Obstet Med | View Thrombocytopenic syndromes in pregnancy | Health care providers | Clinical research |
Circular of information for the use of human blood components: Plasma components | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Plasma components | Health care providers | Benchmarking and standard setting |
Therapeutic Apheresis | Pavenski K | 2018 | Clinical Guide to Transfusion | View Therapeutic Apheresis | Health care providers | Benchmarking and standard setting |
Circulare d'information utilisation de composants sanguins humains: Cellules progénitrices hématopoïétiques de sang de cordon ombilical | Jenkins C | 2020 | Blood.ca website | View Circulare d'information utilisation de composants sanguins humains: Cellules progénitrices hématopoïétiques de sang de cordon ombilical | Health care providers | Benchmarking and standard setting |
Evaluation of immunohematology knowledge in hematology trainees | Yan M, Arsenault V, Pendergrast J | 2019 | Transfusion | View Evaluation of immunohematology knowledge in hematology trainees | Health care providers | Other |
Kell System: Anti-Kpa | Peng S, Meunier D | 2019 | Blood.ca website | View Kell System: Anti-Kpa | Health care providers | Benchmarking and standard setting |
Système MNS : l’anticorps anti-M | Clarke G, Côté J, Lane D | 2019 | Blood.ca website | View Système MNS : l’anticorps anti-M | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Platelets | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
Dépistage et prise en charge de la thrombopénie fœtale et néonatale allo-immune | Meunier D, Clarke G | 2020 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
Jumelage de patients atteints d’anémie falciforme selon le phénotype et période de conservation du sang : examen et recommandations aux fins transfusionnelles | Morin P-A, Skeate R, Clarke G | 2020 | Blood.ca website | View Jumelage de patients atteints d’anémie falciforme selon le phénotype et période de conservation du sang : examen et recommandations aux fins transfusionnelles | Health care providers | Benchmarking and standard setting |
Major clinical trial finds convalescent plasma does not help patients with COVID-19 | Modi D | 2021 | Ontario Regional Blood Coordinating Network December 2021 Newsletter | View Major clinical trial finds convalescent plasma does not help patients with COVID-19 | Health care providers | Clinical research |
Chapter 6: Donor selection, donor testing and pathogen reduction | Drews S, Khandelwal A, Goldman M, Devine D | 2021 | Clinical Guide to Transfusion | View Chapter 6: Donor selection, donor testing and pathogen reduction | Health care providers | Benchmarking and standard setting |
FAQ : Test des titres d’iso-hémagglutinines (anti-A/anti-B) des donneurs à la Société canadienne du sang | Bodnar M, Bienz M, Clarke G | 2022 | Blood.ca website | View FAQ : Test des titres d’iso-hémagglutinines (anti-A/anti-B) des donneurs à la Société canadienne du sang | Health care providers | New or improved product or process |
Transfusion Camp: Successes and challenges in scaling and expanding a transfusion medicine education program | Lin Y, Khandelwal A, Kapitany C, Chargé S | 2023 | Transfus Apher Sci | View Transfusion Camp: Successes and challenges in scaling and expanding a transfusion medicine education program | Health care providers | Education research |
Quality assessment of established and emerging blood components for transfusion | Acker J, Marks DC, Sheffield W | 2016 | J Blood Transfus | View Quality assessment of established and emerging blood components for transfusion | Blood operators | Benchmarking and standard setting |
Summary of adverse transfusion reactions 2017-2022 | Yan M | 2022 | Blood.ca website | View Summary of adverse transfusion reactions 2017-2022 | Blood operators | Benchmarking and standard setting |
Enhanced Pathogenicity of biofilm-negative Staphylococcus epidermidis isolated from platelet preparations | Hodgson SD, Greco-Stewart V, Jimenez CS, Sifri CD, Brassinga AKC, Ramirez-Arcos S | 2014 | Transfusion | View Enhanced Pathogenicity of biofilm-negative Staphylococcus epidermidis isolated from platelet preparations | Blood operators | Basic research |
Stability of relevant plasma protein activities in cryosupernatant plasma units during refrigerated storage for up to 5 days postthaw | Bhakta V, Jenkins C, Ramirez-Arcos S, Sheffield WP | 2014 | Transfusion | View Stability of relevant plasma protein activities in cryosupernatant plasma units during refrigerated storage for up to 5 days postthaw | Blood operators | New or improved product or process |
Transfusion science: integration of proteomics with blood banking | Schubert P, Devine DV | 2011 | Rev Mex Med Tran | View Transfusion science: integration of proteomics with blood banking | Blood operators | Other |
Validation and implementation of a new hemoglobinometer for donor screening at Canadian Blood Services | Goldman M, Uzicanin S, Yi QL, Acker JP, Ramirez-Arcos S | 2012 | Transfusion | View Validation and implementation of a new hemoglobinometer for donor screening at Canadian Blood Services | Blood operators | New or improved product or process |
Evaluation of a pre-exposure prophylaxis (PrEP)/post-exposure prophylaxis (PEP) deferral policy among blood donors | Saeed S, Goldman M, Uzicanin S, O'Brien SF | 2021 | Transfusion | View Evaluation of a pre-exposure prophylaxis (PrEP)/post-exposure prophylaxis (PEP) deferral policy among blood donors | Blood operators | New or improved product or process |
Maintaining trust in a pandemic: Blood collection agency messaging to donors and the public during the early days of COVID-19 | Haw J, Thorpe R, Holloway K | 2021 | SocArXiv | View Maintaining trust in a pandemic: Blood collection agency messaging to donors and the public during the early days of COVID-19 | Blood operators | Ethical, legal and social implications research |
Changing the 30-min Rule in Canada: The Effect of Room Temperature on Bacterial Growth in Red Blood Cells | Ramirez-Arcos S, Kou Y, Ducas É, Thibault L | 2016 | Transfus Med Hemother | View Changing the 30-min Rule in Canada: The Effect of Room Temperature on Bacterial Growth in Red Blood Cells | Blood operators | Benchmarking and standard setting |
Comparison of donor and general population demographics over time: a BEST collaborative group study | Goldman M, Steele WR, Di Angelantonio E, van den Hurk K, Vassallo RR, Germain M, O'Brien SF | 2017 | Transfusion | View Comparison of donor and general population demographics over time: a BEST collaborative group study | Blood operators | Clinical research |